When Do Semaglutide Side Effects Start? Timeline Guide

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Most people starting semaglutide experience their first side effects between day two and day seven of treatment, with peak symptoms typically occurring during weeks one through three. Clinical data shows that roughly 70% of patients report some gastrointestinal symptoms early on, though severity and duration vary widely based on individual factors including genetics, starting dose, and metabolic sensitivity. PlexusDx helps identify your personal peptide response patterns to optimize your treatment experience from day one.

Timeline for Semaglutide Side Effects to Appear

Semaglutide enters your system immediately after injection, but side effects don't always surface right away. Most patients notice the first signs of nausea, appetite suppression, or mild stomach discomfort within 24 to 72 hours of their initial dose. This early window reflects how quickly the medication begins signaling to your brain's appetite centers and slowing gastric emptying.

By day five through day ten, side effects typically reach their most noticeable phase. Nausea often peaks around days 7-10 as your body adjusts to the drug's mechanism. However, some people remain symptom-free during this period, suggesting that individual genetic variations in GLP-1 receptor sensitivity play a significant role in who experiences side effects and when. The Precision Peptide Genetic Test can reveal whether genetic variants like GLP1R rs6923761 influence your expected response timing.

Week two and beyond usually bring either improvement or stabilization of symptoms. Many patients report that nausea begins to fade after 10-14 days as their body adapts to the medication. This adaptation phase is crucial—continuing your prescribed dose during this period, rather than stopping early, often leads to better long-term tolerance and weight loss outcomes.

Most Common Early Side Effects and When They Appear

Nausea stands as the leading side effect reported within the first week of semaglutide therapy, affecting 25-40% of users during initial treatment phases. This symptom typically emerges by day three and can range from mild queasiness to moderate nausea that lasts a few hours daily. Eating smaller, lower-fat meals and staying hydrated often help manage this response without stopping treatment.

Appetite suppression, while the desired therapeutic effect, can feel like a side effect early on if it arrives suddenly or feels too strong. Most people notice reduced hunger and food cravings between days two and five, which is actually the medication working as intended. Constipation frequently develops in parallel with appetite suppression around week one or two, as reduced food intake and slower gut movement combine. Drinking extra water, eating fiber-rich foods when appetite permits, and gentle movement help prevent constipation from becoming bothersome.

Fatigue, mild headache, and dizziness occur less frequently but can appear within the first 5-10 days in sensitive individuals. These symptoms usually resolve on their own within days to weeks as your body adjusts. Vomiting is much rarer with semaglutide than with older GLP-1 drugs and typically only occurs if nausea is ignored or if someone eats large meals early in treatment.

Factors That Influence How Soon You Feel Side Effects

Your genetic makeup directly affects when and how intensely side effects appear. Variations in the GLP1R gene (like rs6923761) and the MC4R gene (rs17782313) can make some people more or less sensitive to semaglutide's effects, including side effects. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to predict your individual response pattern before side effects catch you off guard.

Starting dose significantly shapes your side effect timeline. Lower initial doses (like 0.25 mg) cause fewer early side effects than jumping directly to higher doses. PlexusDx follows a gradual titration approach—starting low and increasing slowly—which gives your body time to adapt and often minimizes the severity of nausea and other early symptoms. Your dose may need to go up over time, but your price won't change, keeping treatment affordable throughout your journey.

Pre-existing digestive conditions, meal composition, hydration level, and stress hormones all influence side effect onset. People with slower gastric emptying at baseline may feel semaglutide's effects more intensely and sooner. Those who eat high-fat meals early in treatment often experience worse nausea than those following a lean-protein-first approach. Adequate sleep and stress management also buffer the perception and severity of side effects.

What to Expect Beyond the First Two Weeks

Most side effects that arrive in week one tend to fade or stabilize by the end of week two to week four. This window represents your body's adaptation phase, where neural and digestive adjustments to semaglutide reach a new equilibrium. Nausea often drops from moderate to mild or disappears entirely, appetite suppression becomes more comfortable and predictable, and any fatigue usually lifts as your metabolism stabilizes.

However, some people experience a longer adjustment curve extending into weeks five through eight. This doesn't mean something is wrong—it simply reflects individual differences in how quickly your GLP-1 and other metabolic receptors adapt to the medication's presence. By month two or month three, most patients report that side effects have become minimal while the appetite-suppressing and weight-loss benefits remain strong. This is the sweet spot where treatment feels sustainable long-term.

If side effects persist intensely beyond four weeks without improving, PlexusDx recommends discussing dose adjustments or timing changes with your care team. Sometimes splitting a dose, taking it at a different time of day, or temporarily pausing the escalation schedule can help. The Precision Peptide Genetic Test may also reveal genetic predispositions that suggest trying a complementary compound like tirzepatide, which activates different peptide pathways and may suit your biology better.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When should I expect nausea to start after my first semaglutide injection?

Most patients report their first experience with nausea between 24 and 72 hours after the initial injection, with peak intensity typically occurring around days 7-10. If you don't feel nausea by day five, you may be among the 30% of users who experience minimal early nausea. Either way, starting low and going slow—the approach PlexusDx follows—r...

How long do semaglutide side effects usually last?

Most side effects peak during the first two weeks and begin improving by week three or four as your body adapts. The majority of patients report that nausea, constipation, and fatigue are either gone or minimal by the end of month one. Some individuals take longer—up to eight weeks—to fully adjust, but this extended timeline doesn't indicate tre...

Can PlexusDx help me prepare for or reduce my semaglutide side effects?

Yes. PlexusDx offers the Precision Peptide Genetic Test, which identifies genetic variants in your GLP1R, MC4R, and FTO genes that predict your sensitivity to side effects and your likely response timeline. Understanding your genetic profile helps you mentally prepare, adjust eating habits proactively, and work with your care team on personalize...

Is it normal to have no side effects at all from semaglutide?

Absolutely. Approximately 30% of patients experience minimal or no nausea and side effects, especially when starting with low doses and titrating gradually as PlexusDx recommends. Some people skip directly to the appetite-suppression benefit without the nausea phase. If this describes you, consider yourself fortunate, and continue following your...

Can my genes predict which side effects I'll experience from semaglutide?

Your genetic variants in the GLP1R and MC4R genes significantly influence your likelihood of experiencing side effects and how quickly they appear. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) examines key variants like GLP1R rs6923761 and MC4R rs17782313 to map your peptide pathway sensitivities acr...

Understanding How Soon You Feel Side Effects from Semaglutide